Jörg Trojan
11PUBLICATIONS
54CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (11)
Sort by Publication Date:
|Feb 25, 2025
Author Correction: Neutralizing GDF-15 can overcome anti-PD-1 and anti-PD-L1 resistance in solid tumours.Ignacio Melero, Maria de Miguel Luken, Guillermo de Velasco
|Feb 04, 2025
Baseline Liquid Biopsy in Relation to Tissue-Based Parameters in Metastatic Colorectal Cancer: Results From the Randomized FIRE-4 (AIO-KRK-0114) Study.Sebastian Stintzing, Susanne Klein-Scory, Ludwig Fischer von Weikersthal
|Dec 11, 2024
Neutralizing GDF-15 can overcome anti-PD-1 and anti-PD-L1 resistance in solid tumours.Ignacio Melero, Maria de Miguel Luken, Guillermo de Velasco
|Feb 26, 2024
Systemic Drugs for Hepatocellular Carcinoma: What Do Recent Clinical Trials Reveal About Sequencing and the Emerging Complexities of Clinical Decisions?Vera Himmelsbach, Christine Koch, Jörg Trojan
|Feb 09, 2023
Impact of IDH1 mutation on clinical course of patients with intrahepatic cholangiocarcinoma: a retrospective analysis from a German tertiary center.Maximilian N Kinzler, Jan Jeroch, Christina Klasen
|Nov 25, 2022
Colonization with multidrug-resistant organisms is associated with impaired survival of patients with surgically resected cholangiocarcinoma.Maximilian N Kinzler, Angelika Stehle, Falko Schulze
Pageof 2
Frequent Collaborators
3 joint publications
Fabian Finkelmeier
2 joint publications
Dirk Walter
2 joint publications
Jorge Esteban-Villarrubia
2 joint publications
Martin Schuler
2 joint publications
Ignacio Melero
2 joint publications
Eugen Leo
2 joint publications
Emiliano Calvo
2 joint publications
Stefan Zeuzem
2 joint publications
Reinhard Dummer
2 joint publications
Elena Garralda
